ESSILORLUXOTTICA 1/2/O.N. Logo
US2972842007

ESSILORLUXOTTICA 1/2/O.N.

Ins Portfolio
Über 2000 Dividenden-Werte in einem kostengünstigen ETF. Jetzt entdecken
Anzeige

Kurse werden geladen...

 Anzeige

Prognose

Kaufen
  0
Halten
  1
Verkaufen
  0

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

  • Foto von EssilorLuxottica: Disclosure of transactions in own shares

    EssilorLuxottica: Disclosure of transactions in own shares

    Disclosure of transactions in own shares Paris, France (May 6, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2024, EssilorLuxottica declares that on April 29, 2025, the following share buybacks were carried out: Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares (€) * Market (MIC Code) ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 29/04/2025 FR0000121667 16,169 249.8663 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 29/04/2025 FR0000121667 6,578 249.9182 CEUX   TOTAL 22,747 249.8813   * Rounded to four decimal places Attachment DOWNLOAD THE PRESS RELEASE» Mehr auf globenewswire.com

  • Foto von Burn Care Market worth $3.35 billion by 2030 with 5.6% CAGR | MarketsandMarkets™

    Burn Care Market worth $3.35 billion by 2030 with 5.6% CAGR | MarketsandMarkets™

    DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Burn Care Market, valued at US$2.46 billion in 2024, is forecasted to grow at a robust CAGR of 5.6%, reaching US$2.55 billion in 2025 and an impressive US$3.35 billion by 2030. This market is experiencing consistent growth due to several key factors. The number of burn injuries is rising due to factors such as industrial accidents, domestic fires, and other hazards. Furthermore, advancements in treatment technologies and increased awareness and education about burn care contribute to this trend. Additionally, supportive government initiatives play a significant role in market development. The demand for effective burn treatments is rising as the global population ages. Older individuals are more susceptible to slow-healing wounds and burn complications, which, in turn, increases the need for advanced burn care products. Moreover, technological advancements in burn treatment—including innovative burn dressings, biologics, and advanced burn wound assessment devices—enhance treatment efficiency and effectiveness. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247121470 Browse in-depth TOC on "Burn Care Market" 345 - Tables 45 - Figures 302 - Pages By Based on products, the burn care market is categorized into five segments: advanced burn dressings, burn wound therapy devices, biologics, traditional burn care products, and other burn care products. Among these, the biologics segment is expected to register the highest CAGR during the forecast period. This growth is driven by the rising demand for advanced and effective treatment options for deep and complex burns. Biologics provide targeted healing, minimize long-term complications, and promote tissue regeneration, making them particularly suitable for treating severe burns. The increasing acceptance of these products among healthcare professionals and ongoing innovations in regenerative medicine are contributing to the strong and sustained growth of the biologics segment. By Based on burn degree, the burn care market is divided into first-degree burns (minor burns), second-degree burns (partial-thickness burns), and third-degree burns (full-thickness burns). Of these, the second-degree burns segment accounted for the largest market share of the burn care market in 2024. This is largely because partial-thickness burns occur more frequently. These burns tend to destroy the epidermis and dermis; as such, they require the application of advanced burn care products, which drives consistent demand in this segment. By geography, the market for burn care is divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the burn care market in 2024 with the largest market share. This is primarily because countries like the US and Canada have well-developed healthcare facilities, supporting widespread access to advanced burn care products and treatments. The region also experiences a high rate of burn injuries. The availability of key players and constant investment in research & development further consolidate North America's position in the burn care market. Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=247121470 The major players operating in this market are Smith+Nephew (UK), Mölnlycke Health Care AB (Sweden), Cardinal Health Inc. (US), Integra LifeSciences Holdings Corporation (US), ConvaTec Group Plc (UK), Coloplast Group (Denmark), Solventum Corporation (US), Essity Aktiebolag (Sweden), PAUL HARTMANN AG (Germany), and Organogenesis Holdings Inc. (US). SMITH+NEPHEW (UK) Smith+Nephew is distinguished by its advanced wound care solutions and robust research and development capabilities, enabling it to provide effective burn care products. Mölnlycke Health Care AB has solidified its market position through strategic partnerships. Cardinal Health Inc. utilizes its extensive distribution network and diverse product line to reach a wide range of healthcare facilities, thereby increasing its share in the burn care market. Integra LifeSciences Holdings Corporation is recognized for its broad range of biologics that offer crucial support for severe burns. ConvaTec Group Plc has strengthened its market presence through global expansion and strategic acquisitions. MOLNLYCKE HEALTH CARE AB (SWEDEN): Mölnlycke Health Care AB also boasts a comprehensive product portfolio in the advanced wound care market. The company's leading position in this sector is largely due to its robust global sales and distribution network, which allows it to effectively market its products in various countries. Mölnlycke primarily utilizes inorganic strategies, such as partnerships, to maintain its market position. For example, in May 2024, the company formed a new partnership with the Phoenix Society, a burn survivor organization in the US. Through this collaboration, Mölnlycke will support the Phoenix Society's initiatives with its extensive range of burn care solutions For more information, Inquire Now! Related Reports: Wound Care Biologics Market Advanced Wound Care Market Point of Care Diagnostics Market Wound Care Market Point of Care Molecular Diagnostics Market Get access to the latest updates on Burn Care Companies and Burn Care Market Size About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: [email protected]Visit Our Website: https://www.marketsandmarkets.com/ Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg» Mehr auf prnewswire.com

  • Foto von EssilorLuxottica: Disclosure of transactions in own shares

    EssilorLuxottica: Disclosure of transactions in own shares

    Disclosure of transactions in own shares Paris, France (April 29, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders' Meeting on April 30, 2024, EssilorLuxottica declares that from April 22, 2025, to April 28, 2025, inclusive, the following share buybacks were carried out: Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares (€) * Market (MIC Code) ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 22/04/2025 FR0000121667 58,184 248.4041 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 22/04/2025 FR0000121667 13,718 248.6304 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 24/04/2025 FR0000121667 18,929 249.5152 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 24/04/2025 FR0000121667 2,474 249.6460 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 24/04/2025 FR0000121667 338 249.5929 TQEX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 24/04/2025 FR0000121667 481 249.6158 AQEU ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 28/04/2025 FR0000121667 30,778 249.9356 XPAR ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 28/04/2025 FR0000121667 15,983 249.9974 CEUX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 28/04/2025 FR0000121667 5,000 249.9855 TQEX ESSILORLUXOTTICA 549300M3VH1A3ER1TB49 28/04/2025 FR0000121667 5,000 249.9807 AQEU   TOTAL 150,885 249.1768   * Rounded to four decimal places Attachment DOWNLOAD THE PRESS RELEASE» Mehr auf globenewswire.com

Dividenden

Alle Kennzahlen
In 2024 hat ESSILORLUXOTTICA 1/2/O.N. +2,00 Dividende ausgeschüttet. Die letzte Dividende wurde im Juni 2024 gezahlt.

Unternehmenszahlen

Im letzten Quartal hatte ESSILORLUXOTTICA 1/2/O.N. einen Umsatz von +13,29 Mrd und ein Nettoeinkommen von +1,37 Mrd
(EUR)Juni 2024
YOY
Umsatz+13,29 Mrd-
Bruttoeinkommen+8,41 Mrd-
Nettoeinkommen+1,37 Mrd-
EBITDA+3,00 Mrd-

Fundamentaldaten

MetrikWert
Marktkapitalisierung
+113,59 Mrd
Anzahl Aktien
909,71 Mio
52 Wochen-Hoch/Tief
+138,03 - +91,81
Dividendenrendite
+1,64%
Dividenden TTM
+2,00
Beta
0,77
KGV (PE Ratio)
+47,80
KGWV (PEG Ratio)
+24,24
KBV (PB Ratio)
+2,79
KUV (PS Ratio)
+4,21

Unternehmensprofil

EssilorLuxottica Société anonyme entwickelt, produziert und vertreibt Brillengläser, Brillenfassungen und Sonnenbrillen in Nordamerika, Europa, Lateinamerika, Asien, Ozeanien und Afrika. Das Unternehmen ist in fünf Segmenten tätig: Großhandel, Einzelhandel, Brillengläser und optische Instrumente, Ausrüstung sowie Sonnenbrillen und Lesegeräte. Das Segment Großhandel befasst sich mit der Herstellung und dem Großhandelsvertrieb von Luxus- und Sportbrillen. Das Segment Einzelhandel vertreibt Luxus- und Sportbrillen. Das Segment Brillengläser und optische Instrumente bietet Brillengläser und Kleingeräte an, darunter Varilux Gleitsichtgläser, Crizal Antireflex-, Antischmutz- und antistatische Brillengläser, Transitions photochrome Brillengläser, Eyezen Brillengläser für Benutzer von Computern, Tablets, Smartphones und anderen vernetzten Geräten, Xperio polarisierte Sonnenbrillengläser sowie Nikon und Kodak Korrektionsgläser. Darüber hinaus bietet das Unternehmen Instrumente zum Einfassen und Montieren von Gläsern für Optiker und Rezeptlabore, Optometrie-Instrumente für Augenärzte, Schulen, arbeitsmedizinische Zentren, das Militär und andere Institutionen sowie Transitions Signature Gen 8 photochrome Gläser an und entwickelt Lösungen für den Online-Verkauf von optischen Produkten. Das Segment Ausrüstung bietet digitale Oberflächenbearbeitungsmaschinen und Linsenbeschichtungsmaschinen für verschreibungspflichtige Labore, integrierte optische Ketten und Linsenhersteller an. Das Segment Sonnenbrillen und Lesebrillen bietet nicht verschreibungspflichtige Sonnenbrillen und Lesebrillen unter den Marken Foster Grant, Gargoyles, Magnivision, Corinne McCormack, Monkey Monkey, Ryders Eyewear und SolarShield; Reebok, Steve Madden, Betsey Johnson, Nine West, Dockers, French Connection, Ironman, Rawlings, Bodyglove, Panama Jack, Marvel und Disney; Bolon, Molsion, Qina und Prosun; und Mujosh und Aojo. Das Unternehmen verfügt über ein Netz von 490 Rezepturlabors und Einrichtungen für die Kantenmontage. Das Unternehmen war früher als Essilor International Société Anonyme bekannt und änderte im Oktober 2018 seinen Namen in EssilorLuxottica Société anonyme. EssilorLuxottica Société anonyme wurde 1849 gegründet und hat seinen Hauptsitz in Paris, Frankreich.

Name
ESSILORLUXOTTICA 1/2/O.N.
CEO
Francesco Milleri
SitzParis,
USA
Website
Börsengang
Mitarbeiter153.498

Ticker Symbole

BörseSymbol
Pnk
ESLOY
Frankfurt
ESLC.F
Düsseldorf
ESLC.DU
München
ESLC.MU

Assets entdecken

Shareholder von ESSILORLUXOTTICA 1/2/O.N. investieren auch in folgende Assets

🍪

Parqet nutzt Cookies.Erfahre Mehr